I2APM Regulatory Activities

Draft Current Recommendations for Implementing and Developing Continuous Manufacturing of Solid Dosage Drug Products in Pharmaceutical Manufacturing

• Each centre’s academic and industry partners have input into the following document: Draft Current Recommendations for Implementing and Developing Continuous Manufacturing of Solid Dosage Drug Products in Pharmaceutical Manufacturing

• The document, which was initiated by C-SOPS in the US, has been shared with the FDA

• This input will help shape regulatory policy, paving the way for wider adoption of continuous manufacturing by industry